Global Blood Clotting Testing Equipment Market Growth 2024-2030

Global Blood Clotting Testing Equipment Market Growth 2024-2030

blood clotting testing equipment are widely used point-of-care (POC) testing devices found primarily in cardiothoracic surgical suites and cardia catheterization laboratories. Most of these devices can perform a number of coagulation tests that provide information about a patient's blood clotting status.

The global Blood Clotting Testing Equipment market size is projected to grow from US$ 2795.3 million in 2023 to US$ 4236.6 million in 2030; it is expected to grow at a CAGR of 6.1% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Blood Clotting Testing Equipment Industry Forecast” looks at past sales and reviews total world Blood Clotting Testing Equipment sales in 2023, providing a comprehensive analysis by region and market sector of projected Blood Clotting Testing Equipment sales for 2024 through 2030. With Blood Clotting Testing Equipment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Clotting Testing Equipment industry.

This Insight Report provides a comprehensive analysis of the global Blood Clotting Testing Equipment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Clotting Testing Equipment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Clotting Testing Equipment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Clotting Testing Equipment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Clotting Testing Equipment.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. The market for coagulation analyzers is expected to witness significant growth due to surging demand for coagulation analyzers across the world owing to growing awareness in healthcare systems. The introduction of new coagulation analyzer tests and rapid technological advancements have improved the efficiency and quality of hemostasis laboratories. That's because these advanced coagulators offer high throughput, reliability, and adaptability, along with precision, accuracy, and easy-to-use software with built-in graphics and calibration curves. Growing awareness of the risks of cardiovascular disease, obesity and high blood pressure has forced people to gather in hospitals and healthcare facilities for routine blood tests. This is expected to aid in the expansion of the coagulation analyzer market and motivate manufacturers to develop better and faster testing methods. Nonetheless, risk of side effects associated with blood testing, coupled with stringent regulations imposed by the government on the approval of coagulation testing devices, are estimated to hamper the demand for hemostasis analyzers. Conversely, sales of coagulation analyzers are likely to increase as manufacturers increasingly rely on expanding their product portfolios to e-commerce platforms.

This report presents a comprehensive overview, market shares, and growth opportunities of Blood Clotting Testing Equipment market by product type, application, key manufacturers and key regions and countries.

Segmentation by type


Standalone Analysers

Table Top Analysers

Portable Analysers
Segmentation by application


Hospitals

Clinical Laboratories

Others
This report also splits the market by region:


Americas
United States
Canada
Mexico
Brazil

APAC
China
Japan
Korea
Southeast Asia
India
Australia

Europe
Germany
France
UK
Italy
Russia

Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.


Siemens

Instrumentation Laboratory

Roche

Mindray

MRC

Helena Laboratories

Thermo Fisher Scientific

ERBA Diagnostics Mannheim

Rayto Life and Analytical Sciences

Nihon Kohden Corporation

Beckman Coulter Inc. (Danaher Corporation)

Sysmex Corporation

Abbott Laboratories

HORIBA Medical

DIRUI Industrial

Seleo

Zircon Biotech

Beijing Succeeder Technology
Key Questions Addressed in this Report

What is the 10-year outlook for the global Blood Clotting Testing Equipment market?

What factors are driving Blood Clotting Testing Equipment market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Blood Clotting Testing Equipment market opportunities vary by end market size?

How does Blood Clotting Testing Equipment break out type, application?


Please note: The report will take approximately 2 business days to prepare and deliver.